13D/13G Filings - Syndax Pharmaceuticals Inc (SNDX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-04-17
09:35 am
Sale
2025-03-31 13G Syndax Pharmaceuticals, Inc.
SNDX
BLACKROCK INC
BLK
6,744,049
7.800%
-2,043,601decrease
(-23.26%)
Filing
History
2025-03-07
11:13 am
Sale
2025-02-28 13G Syndax Pharmaceuticals, Inc.
SNDX
WELLINGTON MANAGEMENT CO LLP 35,681
0.000%
-4,950,295decrease
(-99.28%)
Filing
History
2025-02-14
5:18 pm
Purchase
2024-12-31 13G Syndax Pharmaceuticals, Inc.
SNDX
Kynam Capital Management, LP 8,520,000
9.980%
2,860,000increase
(+50.53%)
Filing
History
2025-02-12
11:39 am
Purchase
2024-12-31 13G Syndax Pharmaceuticals, Inc.
SNDX
GOLDMAN SACHS GROUP INC
GS
5,953,465
7.000%
5,953,465increase
(New Position)
Filing
History
2025-02-05
10:03 am
Purchase
2024-12-31 13G Syndax Pharmaceuticals, Inc.
SNDX
MORGAN STANLEY
MS
5,362,169
6.300%
5,362,169increase
(New Position)
Filing
History
2025-01-22
5:50 pm
Purchase
2025-01-21 13G Syndax Pharmaceuticals, Inc.
SNDX
Point72 Asset Management, L.P. 4,277,847
5.000%
1,443,348increase
(+50.92%)
Filing
History
2024-12-06
4:28 pm
Purchase
2024-11-30 13G Syndax Pharmaceuticals, Inc.
SNDX
BLACKROCK INC
BLK
8,787,650
10.300%
548,570increase
(+6.66%)
Filing
History
2024-11-08
5:31 pm
Unchanged
2024-09-30 13G Syndax Pharmaceuticals, Inc.
SNDX
BLACKROCK INC
BLK
8,239,080
9.700%
0
(Unchanged)
Filing
History
2024-11-08
10:52 am
Sale
2024-09-30 13G Syndax Pharmaceuticals, Inc.
SNDX
WELLINGTON MANAGEMENT CO LLP 4,985,976
5.860%
-2,599,245decrease
(-34.27%)
Filing
History
2024-10-21
4:11 pm
Purchase
2024-09-30 13G Syndax Pharmaceuticals, Inc.
SNDX
BLACKROCK INC
BLK
8,239,080
9.700%
1,223,532increase
(+17.44%)
Filing
History
2024-10-18
11:49 am
Sale
2024-09-30 13G Syndax Pharmaceuticals, Inc.
SNDX
STATE STREET CORP
STT
3,770,826
4.400%
-1,245,398decrease
(-24.83%)
Filing
History
2024-02-14
12:50 pm
Purchase
2023-12-31 13G Syndax Pharmaceuticals, Inc.
SNDX
Kynam Capital Management, LP 5,660,000
6.670%
5,660,000increase
(New Position)
Filing
History
2024-02-14
07:01 am
Sale
2023-12-31 13G Syndax Pharmaceuticals, Inc.
SNDX
Point72 Asset Management, L.P. 2,834,499
3.300%
-685,903decrease
(-19.48%)
Filing
History
2024-02-13
9:44 pm
Sale
2023-12-31 13G Syndax Pharmaceuticals, Inc.
SNDX
Avidity Partners Management LP 3,950,000
4.700%
-2,768,142decrease
(-41.20%)
Filing
History
2024-02-13
5:15 pm
Purchase
2023-12-29 13G Syndax Pharmaceuticals, Inc.
SNDX
The Vanguard Group 4,335,353
5.110%
4,335,353increase
(New Position)
Filing
History
2024-02-08
10:18 am
Sale
2023-12-29 13G Syndax Pharmaceuticals, Inc.
SNDX
WELLINGTON MANAGEMENT CO LLP 7,585,221
8.940%
-398,221decrease
(-4.99%)
Filing
History
2024-01-25
4:59 pm
Purchase
2023-12-31 13G Syndax Pharmaceuticals, Inc.
SNDX
BLACKROCK INC
BLK
7,015,548
8.300%
2,663,516increase
(+61.20%)
Filing
History
2024-01-25
11:20 am
Purchase
2023-12-31 13G Syndax Pharmaceuticals, Inc.
SNDX
STATE STREET CORP
STT
5,016,224
5.910%
1,367,761increase
(+37.49%)
Filing
History
2023-10-31
4:26 pm
Purchase
2023-10-30 13G Syndax Pharmaceuticals, Inc.
SNDX
Point72 Asset Management, L.P. 3,520,402
5.100%
3,520,402increase
(New Position)
Filing
History
2023-10-05
12:23 pm
Sale
2023-10-03 13G Syndax Pharmaceuticals, Inc.
SNDX
Frazier Life Sciences Public Fund, L.P. 0
0.000%
-3,708,838decrease
(Position Closed)
Filing
History
Goto 0, 1, 2, Next